Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuronal α7 Nicotinic Receptors as a Target for the Treatment of Schizophrenia
Tanya L. Wallace, Daniel Bertrand
International review of neurobiology (2015), pp. 79-111
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Current Concepts and Treatments of Schizophrenia
Piotr Stępnicki, Magda Kondej, Agnieszka A. Kaczor
Molecules (2018) Vol. 23, Iss. 8, pp. 2087-2087
Open Access | Times Cited: 467
Treating Negative Symptoms in Schizophrenia: an Update
Gary Remington, George Foussias, Gagan Fervaha, et al.
Current Treatment Options in Psychiatry (2016) Vol. 3, Iss. 2, pp. 133-150
Open Access | Times Cited: 154
The wonderland of neuronal nicotinic acetylcholine receptors
Daniel Bertrand, Alvin V. Terry
Biochemical Pharmacology (2017) Vol. 151, pp. 214-225
Closed Access | Times Cited: 114
Theranostic Biomarkers for Schizophrenia
Matea Nikolac Perković, Gordana Nedić Erjavec, Dubravka Švob Štrac, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 4, pp. 733-733
Open Access | Times Cited: 99
Brain PET Imaging of α7-nAChR with [18F]ASEM: Reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia
Dean F. Wong, Hiroto Kuwabara, Andrew G. Horti, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 21, Iss. 7, pp. 656-667
Open Access | Times Cited: 53
Functional characterization of α7 nicotinic acetylcholine and NMDA receptor signaling in SH-SY5Y neuroblastoma cells in an ERK phosphorylation assay
Mohamed R. Elnagar, Anne B. Walls, Gouda K. Helal, et al.
European Journal of Pharmacology (2018) Vol. 826, pp. 106-113
Closed Access | Times Cited: 49
Inhibition of kynurenine aminotransferase II attenuates hippocampus‐dependent memory deficit in adult rats treated prenatally with kynurenine
Ana Pocivavsek, Gregory I. Elmer, Robert Schwarcz
Hippocampus (2018) Vol. 29, Iss. 2, pp. 73-77
Open Access | Times Cited: 48
Nicotinic Acetylcholine Receptor Ligands, Cognitive Function, and Preclinical Approaches to Drug Discovery
Alvin V. Terry, Patrick M. Callahan
Nicotine & Tobacco Research (2018) Vol. 21, Iss. 3, pp. 383-394
Open Access | Times Cited: 35
Nicotine protects against manganese and iron-induced toxicity in SH-SY5Y cells: Implication for Parkinson's disease
Bruk Getachew, Antonei B. Csòka, Michael Aschner, et al.
Neurochemistry International (2018) Vol. 124, pp. 19-24
Open Access | Times Cited: 34
Water‐soluble variant of human Lynx1 positively modulates synaptic plasticity and ameliorates cognitive impairment associated with α7‐nAChR dysfunction
Захар О. Шенкарев, Mikhail A. Shulepko, М. Л. Бычков, et al.
Journal of Neurochemistry (2020) Vol. 155, Iss. 1, pp. 45-61
Open Access | Times Cited: 32
Combining CDP-choline and galantamine, an optimized α7 nicotinic strategy, to ameliorate sensory gating to speech stimuli in schizophrenia
Joëlle Choueiry, Crystal Blais, Dhrasti Shah, et al.
International Journal of Psychophysiology (2019) Vol. 145, pp. 70-82
Closed Access | Times Cited: 20
Combining CDP-choline and galantamine: Effects of a selective α7 nicotinic acetylcholine receptor agonist strategy on P50 sensory gating of speech sounds in healthy volunteers
Joëlle Choueiry, Crystal Blais, Dhrasti Shah, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 6, pp. 688-699
Closed Access | Times Cited: 16
Structural Diversity and Dynamics of Human Three-Finger Proteins Acting on Nicotinic Acetylcholine Receptors
Alexander S. Paramonov, Milita V. Kocharovskaya, Andrey V. Tsarev, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7280-7280
Open Access | Times Cited: 16
Serum levels of TNF-alpha in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the PULSAR study)
Dominik Strzelecki, Małgorzata Urban‐Kowalczyk, Adam Wysokiński
Psychiatry Research (2018) Vol. 268, pp. 447-453
Closed Access | Times Cited: 15
Genome-wide analyses of smoking behaviors in schizophrenia: Findings from the Psychiatric Genomics Consortium
Roseann E. Peterson, Tim B. Bigdeli, Stephan Ripke, et al.
Journal of Psychiatric Research (2021) Vol. 137, pp. 215-224
Open Access | Times Cited: 12
Selective adrenergic alpha2C receptor antagonist ameliorates acute phencyclidine-induced schizophrenia-like social interaction deficits in rats
Katja Savolainen, Jouni Ihalainen, Aaro J. Jalkanen, et al.
Psychopharmacology (2018) Vol. 236, Iss. 4, pp. 1245-1253
Open Access | Times Cited: 12
Human Nicotinic Acetylcholine Receptors: Part I—Structure, Function, and Role in Neuromuscular Transmission and CNS Functioning
Dmitrii S. Kulbatskii, М. Л. Бычков, Ekaterina N. Lyukmanova
Russian Journal of Bioorganic Chemistry (2018) Vol. 44, Iss. 6, pp. 595-607
Closed Access | Times Cited: 9
An α7 nAChR approach for the baseline-dependent modulation of deviance detection in schizophrenia: A pilot study assessing the combined effect of CDP-choline and galantamine
Joëlle Choueiry, Crystal Blais, Dhrasti Shah, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 4, pp. 381-395
Open Access | Times Cited: 3
Pharmacophore Mapping Combined with dbCICA Reveal New Structural Features for the Development of Novel Ligands Targeting α4β2 and α7 Nicotinic Acetylcholine Receptors
Victor S. Batista, Adriano Marques Gonçalves, Nailton M. Nascimento-Júnior
Molecules (2022) Vol. 27, Iss. 23, pp. 8236-8236
Open Access | Times Cited: 5
CDP-choline and galantamine, a personalized α7 nicotinic acetylcholine receptor targeted treatment for the modulation of speech MMN indexed deviance detection in healthy volunteers: a pilot study
Joëlle Choueiry, Crystal Blais, Dhrasti Shah, et al.
Psychopharmacology (2020) Vol. 237, Iss. 12, pp. 3665-3687
Closed Access | Times Cited: 7
A-582941, cholinergic alpha 7 nicotinic receptor agonist, improved cognitive and negative symptoms of the sub-chronic MK-801 model of schizophrenia in rats
Gökhan Ünal, Feyza Arıcıoğlu
Psychiatry and Clinical Psychopharmacology (2017) Vol. 28, Iss. 1, pp. 4-13
Open Access | Times Cited: 6
PET Brain imaging of α7-nAChR with [18F]ASEM Reproducibility, occupancy, receptor density, and changes in schizophrenia
Dean F. Wong, Hiroto Kuwabara, Andrew G. Horti, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2018), pp. 245118
Open Access | Times Cited: 4
PET Brain imaging of α7-nAChR with [18F]ASEM
Dean F. Wong, Hiroto Kuwabara, Andrew G. Horti, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2018)
Open Access | Times Cited: 4
Theories of the pathogenesis of schizophrenia
Justyna Dąbrowska, Magdalena Wójcik, Julita Szarpak, et al.
Journal of Education Health and Sport (2020) Vol. 10, Iss. 8, pp. 332-339
Open Access | Times Cited: 3
Managing Schizophrenia: A Challenge for Physicians
Nimra Mumtaz, Muhammad Omair Hassan
(2023), pp. 127-147
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top